Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Grant/Award of 19,801 TELA shares, $20.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | TELA Bio, Inc. (TELA) | Grant/Award | 19,801 | $20.0K |
| Sep 18, 2026 | TELA Bio, Inc. (TELA) | Purchase | 50,000 | $58.3K |
| Sep 16, 2026 | TELA Bio, Inc. (TELA) | Purchase | 25,000 | $25.5K |
| Jul 17, 2026 | TELA Bio, Inc. (TELA) | Grant/Award | 6,227 | $4.9K |
| Jun 23, 2026 | Anika Therapeutics, Inc. (ANIK) | Grant/Award | 10,402 | n/a |
| Jun 11, 2026 | TELA Bio, Inc. (TELA) | Grant/Award | 11,925 | n/a |
| Mar 6, 2026 | MIMEDX GROUP, INC. (MDXG) | Grant/Award | 371,094 | n/a |
| Jun 24, 2025 | Anika Therapeutics, Inc. (ANIK) | Grant/Award | 14,164 | n/a |
| May 5, 2025 | MIMEDX GROUP, INC. (MDXG) | Purchase | 200,000 | $1.27M |
| Mar 5, 2025 | MIMEDX GROUP, INC. (MDXG) | Grant/Award | 223,268 | n/a |